Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $27,601,114 |
Sells | 17 | $1,173,761 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
08 Jan 2024 17:50 | RAPT | RAPT Therapeutics Inc | BROCKSTEDT DIRK G. | CHIEF SCIENTIFIC OFFICER | 05 Jan 2024 | Sale | 898 | 22.78 | 20,456 | D |
22 Dec 2023 14:31 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 21 Dec 2023 | Sale | 2,500 | 21.68 | 54,200 | D |
29 Nov 2023 14:29 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 28 Nov 2023 | Sale | 1,500 | 13.72 | 20,580 | D |
04 Oct 2023 18:29 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 03 Oct 2023 | Sale | 2,500 | 15.77 | 39,425 | D |
22 Aug 2023 12:19 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 18 Aug 2023 | Sale | 2,500 | 18.92 | 47,300 | D |
20 Apr 2023 14:17 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 19 Apr 2023 | Sale | 5,000 | 18.88 | 94,400 | D |
15 Mar 2023 18:48 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 14 Mar 2023 | Purchase | 2,500 | 20.05 | 50,125 | I |
15 Mar 2023 18:48 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 14 Mar 2023 | Purchase | 600 | 19.95 | 11,970 | D |
15 Mar 2023 18:48 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 14 Mar 2023 | Purchase | 400 | 18.48 | 7,392 | D |
15 Mar 2023 18:48 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 14 Mar 2023 | Purchase | 1,500 | 18.75 | 28,125 | D |
13 Mar 2023 14:21 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 07 Mar 2023 | Sale | 5,000 | 29.62 | 148,100 | D |
26 Jan 2023 14:29 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 24 Jan 2023 | Sale | 5,000 | 30 | 150,000 | D |
20 Jan 2023 18:33 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 19 Jan 2023 | Sale | 5,000 | 25.56 | 127,800 | D |
09 Jan 2023 15:17 | RAPT | RAPT Therapeutics Inc | BROCKSTEDT DIRK G. | Chief Scientific Officer | 05 Jan 2023 | Sale | 742 | 21.966 | 16,299 | D |
30 Dec 2022 18:57 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 29 Dec 2022 | Sale | 5,000 | 18.03 | 90,150 | D |
29 Nov 2022 14:49 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 28 Nov 2022 | Sale | 5,000 | 17.87 | 89,350 | D |
03 Nov 2022 18:44 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 02 Nov 2022 | Sale | 5,000 | 22.32 | 111,600 | D |
14 Oct 2022 14:41 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 13 Oct 2022 | Sale | 2,000 | 21.52 | 43,040 | D |
31 Aug 2022 14:33 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 30 Aug 2022 | Sale | 2,500 | 28.13 | 70,325 | D |
13 Jul 2022 17:33 | RAPT | RAPT Therapeutics Inc | HO WILLIAM | Chief Medical Officer | 11 Jul 2022 | Sale | 2,000 | 19.95 | 39,900 | D |
27 May 2022 16:29 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 25 May 2022 | Purchase | 63 | 12.4549 | 785 | I |
27 May 2022 16:29 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 25 May 2022 | Purchase | 1,837 | 12.4549 | 22,880 | I |
27 May 2022 16:24 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 25 May 2022 | Purchase | 63 | 12.4549 | 785 | I |
27 May 2022 16:24 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 25 May 2022 | Purchase | 1,837 | 12.4549 | 22,880 | I |
25 May 2022 16:20 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 24 May 2022 | Purchase | 538 | 12.0021 | 6,457 | I |
25 May 2022 16:20 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 24 May 2022 | Purchase | 15,776 | 12.0021 | 189,345 | I |
25 May 2022 16:20 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 23 May 2022 | Purchase | 338 | 12.4993 | 4,225 | I |
25 May 2022 16:20 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 23 May 2022 | Purchase | 9,898 | 12.4993 | 123,718 | I |
25 May 2022 16:19 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 24 May 2022 | Purchase | 538 | 12.0021 | 6,457 | I |
25 May 2022 16:19 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 24 May 2022 | Purchase | 15,776 | 12.0021 | 189,345 | I |
25 May 2022 16:19 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 23 May 2022 | Purchase | 338 | 12.4993 | 4,225 | I |
25 May 2022 16:19 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 23 May 2022 | Purchase | 9,898 | 12.4993 | 123,718 | I |
12 May 2022 17:29 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 10 May 2022 | Purchase | 41,250 | 10.6715 | 440,199 | I |
12 May 2022 17:29 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 10 May 2022 | Purchase | 1,208,750 | 10.6715 | 12,899,176 | I |
12 May 2022 17:28 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 10 May 2022 | Purchase | 41,250 | 10.6715 | 440,199 | I |
12 May 2022 17:28 | RAPT | RAPT Therapeutics Inc | COLUMN GROUP II, LP | 10% | 10 May 2022 | Purchase | 1,208,750 | 10.6715 | 12,899,176 | I |
12 May 2022 17:00 | RAPT | RAPT Therapeutics Inc | YOUNG RODNEY KB | Chief Financial Officer | 10 May 2022 | Purchase | 5,000 | 10.53 | 52,650 | D |
12 May 2022 16:59 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 10 May 2022 | Purchase | 400 | 10.62 | 4,248 | I |
12 May 2022 16:59 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 10 May 2022 | Purchase | 600 | 10.49 | 6,294 | I |
12 May 2022 16:59 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 10 May 2022 | Purchase | 1,000 | 10.51 | 10,510 | I |
12 May 2022 16:59 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 10 May 2022 | Purchase | 500 | 11.3 | 5,650 | I |
12 May 2022 16:59 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 10 May 2022 | Purchase | 2,500 | 11.8 | 29,500 | D |
12 May 2022 16:59 | RAPT | RAPT Therapeutics Inc | ROBBINS WENDYE | Director | 10 May 2022 | Purchase | 2,000 | 10.54 | 21,080 | D |
05 May 2022 13:28 | RAPT | RAPT Therapeutics Inc | BROCKSTEDT DIRK G. | Chief Scientific Officer | 04 May 2022 | Sale | 720 | 15.05 | 10,836 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)